https://orcid.org/0000-0002-2870-5454
References
- Wali Y, Kini V, Yassin MA. Distribution of sickle cell disease and assessment of risk factors based on transcranial Doppler values in the Gulf region. Hematology. 2020;25(1):55–62. doi:10.1080/16078454.2020.1714113
- Alhumaid AM, Aleidi AS, Alfakhri AS, et al. Clinical features and outcome of sickle cell anemia in a tertiary center: a retrospective cohort study. J Appl Hematol. 2018;9:22–28. doi:10.4103/joah.joah_48_17
- El-Hazmi MA, Al-Hazmi AM, Warsy AS. Sickle cell disease in Middle East Arab countries. Indian J Med Res. 2011;134(5):597–610. doi:10.4103/0971-5916.90984
- Memish ZA, Owaidah TM, Saeedi MY. Marked regional variations in the prevalence of sickle cell disease and β-thalassemia in Saudi Arabia: findings from the premarital screening and genetic counseling program. J Epid and Global Health. 2011;1:61–68. doi:10.1016/j.jegh.2011.06.002
- Hawasawi ZM, Nabi G, Al Magamci MS, et al. Sickle cell anemia in childhood in Madina. Ann Saudi Med. 1998;18:293–295. doi:10.5144/0256-4947.1998.293
- Maf EH, Warsy AS. Hemoglobinopathies in Arab countries. In: Teebi AS, Farag TL, editors. Genetic Disorders Among Arab Populations. New York: Oxford University Press; 1997:83–110.
- Salman ZA, Hassan MK. Hospitalization events among children and adolescents with sickle cell disease in Basra, Iraq. Anemia. 2015;25(5):55–62.
- McClish DK, Penberthy LT, Bovbjerg VE, et al. Health related quality of life in sickle cell patients: the PiSCES project. Health Qual Life Outcomes. 2005;3:50. doi:10.1186/1477-7525-3-50
- Anie KA. Psychological complications in sickle cell disease. Br J Haematol. 2005;129:723–729. doi:10.1111/j.1365-2141.2005.05500.x
- Bhagat VM, Baviskar SR, Mudey AB, et al. Poor health related quality of life among patients of sickle cell disease. Indian J Palliat Care. 2014;20(2):107–111. doi:10.4103/0973-1075.132622
- Abd Elmoneim AA, Al Hawsawi ZM, Mahmoud BZ, et al. Causes of hospitalization in sickle cell diseased children in western region of Saudi Arabia. A single center study. Saudi Med J. 2019;40(4):401–404. doi:10.15537/smj.2019.4.24049
- Alsulami SH, Alotaibi MN, Alfaraj EA, et al. Evaluation of the most common complications of sickle cell anemia and management in children: simple literature review. EJHM. 2018;72(2):3951–3960. doi:10.21608/ejhm.2018.9076
- Platt OS, Thorington BD, Brambilla DJ, et al. Pain in sickle cell disease. Rates and risk factors. N Engl J Med. 1991;325(1):11–16. doi:10.1056/NEJM199107043250103
- Kauf TL, Coates TD, Huazhi L, et al. The cost of health care for children and adults with sickle cell disease. AJH. 2018;84(6):323–327.
- Madigan C, Malik P. Pathophysiology and therapy for haemoglobinopathies. Part I: sickle cell disease. Expert Rev Mol Med. 2006;8(9):1–23. doi:10.1017/S1462399406010659
- Akar NA, Adekile A. Ten-year review of hospital admissions among children with sickle cell disease in Kuwait. Med Princ Pract. 2008;17(5):404–408. doi:10.1159/000141506
- Jaiyesimi F, Pandey R, Bux D, et al. Sickle cell morbidity profile in Omani children. Ann Trop Paediatr. 2002;22(1):45–52. doi:10.1179/027249302125000148
- Brown BJ, Jacob NE, Lagunju IA, et al. Morbidity and mortality pattern in hospitalized children with sickle cell disorders at the University College Hospital, Ibadan, Nigeria. Niger J Pediatr. 2013;40(1):34–39.
- Alkot M, Almaghrabi WA, Al-Najdi N, et al. Prevalence of complications of sickle cell disease at Makkah Al-Mukaramah, Saudi Arabia, 2017. Ann Clin Lab Res. 2018;6(1):226. doi:10.21767/2386-5180.1000226
- Yale SH, Nagib N, Guthrie T. Approach to the vasoocclusive crisis in adults with sickle cell disease. Am Fam Physician. 2000;61:1349–1356.
- Booth C, Inusa B, Obaro SK. Infection in sickle cell disease: a review. Int J Infect Dis. 2010;14:e2–e12. doi:10.1016/j.ijid.2009.03.010
- Howard J, Hart N, Roberts-Harewood M, et al. Guideline on the management of acute chest syndrome in sickle cell disease. Br J Haematol. 2015;169:492–505. doi:10.1111/bjh.13348
- Ballas SK, Bauserman RL, McCarthy WF, et al. Hydroxyurea and acute painful crises in sickle cell anemia: effects on hospital length of stay and opioid utilization during hospitalization, outpatient acute care contacts, and at home. J Pain Symptom Manage. 2010;40(6):870–882. doi:10.1016/j.jpainsymman.2010.03.020
- Mulaku M, Opiyo N, Karumbi J, et al. Evidence review of hydroxyurea for the prevention of sickle cell complications in low-income countries. Arch Dis Child. 2013;98(11):908–914. doi:10.1136/archdischild-2012-302387